University of Cincinnati Cancer Center’s Post

September is Leukemia and Lymphoma Awareness Month, a time to focus on finding better ways to prevent and treat these blood cancers that affect thousands each year. The National Cancer Institute estimates over 62,000 new cases of leukemia will be diagnosed in 2024. At the University of Cincinnati Cancer Center, our researchers are working tirelessly to improve treatments, including Eric Vick, MD, PhD. Dr. Vick was awarded Leukemia & Lymphoma Society and ASCO grant funding to further his research on combination therapies targeting AML. Read more about how Dr. Vick's work could lead to innovative, life-saving treatments: https://lnkd.in/gtqXD9wD #LeukemiaAwareness #LymphomaAwareness #CancerResearch

The University of Cincinnati Cancer Center's Fundraising team is growing! Interested in supporting our region's only academic medical center in the fight against cancer? Learn more about the Associate Director of Development and Assistant Director of Development roles to support our cancer fundraising efforts. https://lnkd.in/gsc3z9Wn https://lnkd.in/guWDzQpn

We’re proud to highlight the transformative impact of Ride Cincinnati on our cancer research. Blood cancers are a strategic priority for our Cancer Center, and thanks to a $50,000 Pilot Project Award funded by Ride Cincinnati, Erin Hertlein, PhD, is leading a critical project to identify mechanisms of immune suppression in Acute Myeloid Leukemia. Since 2018, Ride Cincinnati has funded over 80 research projects at the University of Cincinnati Cancer Center, driving innovation and improving health outcomes in our region. Join this fun, impactful event next weekend and help us continue this life-saving work. It's not too late to sign up. Riders can choose 10, 15, 24, 36 or 64 miles or choose the virtual option. https://lnkd.in/g52Uz4S2

We’re proud to highlight the transformative impact of Ride Cincinnati on our cancer research. Blood cancers are a strategic priority for our Cancer Center, and thanks to a $50,000 Pilot Project Award funded by Ride Cincinnati, Erin Hertlein, PhD, is leading a critical project to identify mechanisms of immune suppression in Acute Myeloid Leukemia. Since 2018, Ride Cincinnati has funded over 80 research projects at the University of Cincinnati Cancer Center, driving innovation and improving health outcomes in our region. Join this fun, impactful event next weekend and help us continue this life-saving work. It's not too late to sign up. Riders can choose 10, 15, 24, 36 or 64 miles or choose the virtual option. https://lnkd.in/d9UPXdJT

This September, we recognize Childhood Cancer Awareness Month, a time to reflect on the challenges and progress in pediatric cancer care. While pediatric cancers are relatively rare, they are the leading cause of death from disease in children aged 1 to 14. Thanks to ongoing research and innovative treatments, the five-year survival rate has improved significantly from 58-68% in the 1970s to 83-88% today. At the University of Cincinnati Cancer Center, we are dedicated to advancing cancer research and care across the lifespan. Our partners at Cincinnati Children's, the nation’s #1 ranked children’s hospital, are key to this mission. Their Cancer and Blood Diseases Institute (CBDI) leads globally in treating and researching high-risk, relapsed, and refractory cancers, blood diseases, and immune deficiencies in children and young adults. Alongside the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center, these teams deliver comprehensive, innovative care from bench to bedside, continually improving outcomes for patients and their families. September brings awareness to multiple cancers—follow along this month to learn more about the University of Cincinnati Cancer Center’s impact across these areas.

We're proud of the impact that Ride Cincinnati's funds have on cancer research in our community. Thanks to this support, researchers like Jordan Kharofa, MD, are advancing treatments for cancers most prevalent in our catchment area, such as anal cancer. Dr. Kharofa’s REDEL Trial is pioneering a new approach to reduce treatment toxicity, directly benefiting patients. This work not only drives innovation but also brings us closer to our mission of improving health outcomes in our community. Read the full story: https://lnkd.in/g3cgDetw #CancerResearch

Congratulations to Alique Topalian, PhD, MPH, on receiving the Inspirational Award from the Armenian Bone Marrow Donor Registry! Dr. Topalian's journey and dedication inspire us all. The ABMDR, which was founded during her first battle with acute myeloid leukemia, has since registered over 30,000 donors and performed 44 life-saving transplants, bringing vital resources and innovation to Armenia. We are honored to celebrate her remarkable journey and contributions to advancing life-saving resources and innovation in the Caucasus region.

Congrats to Cancer Center members Chenran Wang, PhD, Amanda Wasylishen, PhD, Yanbo Fan, MD, PhD, and Ady Kendler, MD, PhD, on their new publication! Their research introduces a novel 3D co-culture platform using human cerebral organoids to model breast cancer brain metastasis. This innovative approach has revealed that certain breast cancer cells, like MDA-MB-231 and SUM159PT, can invade and form colonies in the brain, advancing our understanding of the tumor microenvironment and potentially leading to more effective therapies for patients. Learn more: https://lnkd.in/gS9pnEhp